Internal Medicine
Video: Coronavirus Update with Carlos del Rio and Preeti Malani
19 Mar, 2021 | 08:24h | UTCCoronavirus Update With Carlos del Rio and Preeti Malani – JAMA
Perspective | Five reasons why COVID herd immunity is probably impossible
19 Mar, 2021 | 08:19h | UTCFive reasons why COVID herd immunity is probably impossible – Nature
Review: Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke
18 Mar, 2021 | 08:54h | UTCDiagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review – JAMA
Review: Preoperative management of surgical patients using dietary supplements
18 Mar, 2021 | 08:53h | UTCPreoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
WHO Guideline: Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
18 Mar, 2021 | 08:55h | UTCNews release: WHO publishes new clinical and service delivery recommendations for HIV prevention, treatment and care
Opinion | “’It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine”
18 Mar, 2021 | 09:14h | UTC‘It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine – Science (a few articles per month are free)
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
WHO Statement | The benefits of the AstraZeneca vaccine outweigh its risks – vaccinations should continue
18 Mar, 2021 | 09:17h | UTCWHO statement on AstraZeneca COVID-19 vaccine safety signals – World Health Organization
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
Commentary on Twitter (thread – click for more)
At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue.
Full statement on AstraZeneca #COVID19 vaccine safety signals:
👉 https://t.co/9J6MtxXWK8 pic.twitter.com/fWGzqbjMuE— World Health Organization (WHO) (@WHO) March 17, 2021
Opinion | “The zero-risk mentality stifling Europe is now killing its people”
18 Mar, 2021 | 09:11h | UTCThe zero-risk mentality stifling Europe is now killing its people – The Sidney Morning Herald
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
18 Mar, 2021 | 09:05h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Opinion | “Oxford-AstraZeneca Vaccine Safety: Reports of blood clots after receiving the AstraZeneca COVID-19 vaccine are very likely just background events.”
18 Mar, 2021 | 09:09h | UTCRelated: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries) AND What is Going on With the AstraZeneca/Oxford Vaccine? – Science Translational Medicine
Just How Do Deaths Due to COVID-19 Stack Up?
18 Mar, 2021 | 09:03h | UTCJust How Do Deaths Due to COVID-19 Stack Up? – Think Global Health
Commentary on Twitter (thread – click for more)
The Americas and Europe accounted for 80% of COVID-19 deaths globally, even though they represent only a quarter of the world's population. @ThinkGlobalHlth launches a tracker of COVID as a cause of death globally and the factors driving those trends 1/https://t.co/t6xp2yAWA4 pic.twitter.com/SJ9DRdlu1e
— Tom Bollyky (@TomBollyky) March 17, 2021
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
18 Mar, 2021 | 09:00h | UTCFour-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 – JAMA
Editorial: Outcomes for Patients Following Hospitalization for COVID-19
Why Opening Windows Is a Key to Reopening Schools
18 Mar, 2021 | 09:02h | UTCWhy Opening Windows Is a Key to Reopening Schools – The New York Times (free registration may be required)
Commentary on Twitter
https://twitter.com/trishgreenhalgh/status/1372180956094865409
COVID-19 vaccines vs. variants—determining how much immunity is enough
18 Mar, 2021 | 08:58h | UTCCOVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough – JAMA
Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older
18 Mar, 2021 | 09:06h | UTCCommentaries: Risk of SARS-CoV-2 reinfection after natural infection – The Lancet AND COVID-19 Reinfection: More Common Than We Think? – MedPage Today (free registration required)
Commentary on Twitter
NEW—Most people who have had original #COVID19 strain are protected from catching it again for at least 6 months—but those ≥65 years are more prone to reinfection, suggests first large-scale study of its kind. Read https://t.co/250Yv0a9BZ pic.twitter.com/BTjhcMzXwT
— The Lancet (@TheLancet) March 17, 2021
USPSTF Draft Statement: Start screening for Prediabetes and Type 2 Diabetes Mellitus in adults ages 35 to 70 years who are overweight or obese
17 Mar, 2021 | 02:41h | UTCCommentary: USPSTF Lowers Age for Diabetes Screening in Draft Recommendation – NEJM Journal Watch
RCT: No benefit from marine Omega-3 fatty acid and Vitamin D supplementation on incident atrial fibrillation
17 Mar, 2021 | 02:38h | UTCEffect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Omega-3 Fatty Acids and Atrial Fibrillation – JAMA (free for a limited period)
Systematic review | Hospital at home: home‐based end‐of‐life care
17 Mar, 2021 | 02:31h | UTCHospital at home: home‐based end‐of‐life care – Cochrane Library
Summary: Home-based end-of-life care – Cochrane Library
Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy
17 Mar, 2021 | 02:28h | UTC
Systematic review: Interventions for cutaneous disease in systemic lupus erythematosus
17 Mar, 2021 | 02:30h | UTCInterventions for cutaneous disease in systemic lupus erythematosus – Cochrane Library
Podcast | Abdominal pain: Physical exam series
17 Mar, 2021 | 02:25h | UTC#261, #262 Abdominal Pain: Physical Exam Series – The Curbsiders Internal Medicine Podcast
RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant
17 Mar, 2021 | 03:01h | UTCCommentaries: AstraZeneca vaccine doesn’t prevent B1351 COVID in early trial – CIDRAP AND Oxford/AstraZeneca Fails to Prevent Mild to Moderate Covid-19 From B.1.351 (“South Africa”) Variant – Brief19
FDA: Why you should not use Ivermectin to treat or prevent COVID-19
17 Mar, 2021 | 02:51h | UTCWhy You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration
Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19
Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
17 Mar, 2021 | 02:52h | UTC
Commentary on Twitter
How common are pre‐existing heart & blood vessel problems in #COVID19? What are most common complications affecting heart & blood vessels in #COVID19? @CochraneHeart review of prevalence studies: https://t.co/rDqz2GyrpH
— The Cochrane Library (@CochraneLibrary) March 12, 2021
COVID antibody treatments show promise for preventing severe disease
17 Mar, 2021 | 02:46h | UTCCOVID antibody treatments show promise for preventing severe disease – Nature